Browsing: exploring

GLP-1 receptor agonists are changing the way chronic conditions like type 2 diabetes are managed, but they have also been…

By David Carnevali, Mike Stone, Allison Lampert and Tim Hepher (Reuters) – Boeing (NYSE:) and Airbus are edging towards a…